Greystone Associates       Home Contact Site Map

 

Research Reports Advisories News/Events About Greystone
 

   Drug Delivery

  Transmucosal Drug Delivery  
  Systemic Therapies and Markets

Related Reports
Active Transdermal
Disposable Injection
Drug Formulation
Dry Powder Inhalation
Injectable Drug Delivery
Inhalation Therapeutics
Intranasal
Iontophoresis
Metered Dose Inhalers
Microneedles
Nanoparticle Delivery
Needle-free Injection
Pediatric Delivery
Pen Injectors
Prefilled Syringes
Protein Delivery
Retractable Syringes
Skin Patches
Transmucosal Delivery

In their search for alternative delivery methods that will enhance compliance and improve safety, drug developers and researchers are discovering that the permeability of mucous membranes provides a convenient route for the systemic delivery of new and existing therapeutic drugs. Transmucosal delivery offers the potential for once daily dosing of oral drugs and avoids the effects of first pass metabolism. We expect this market to experience rapid growth beginning in 2009 as   transmucosal technology is applied to existing drugs and as transmucosal formulations become an important route of administration for an increasing number of new NCEs. Growth in this sector will also be driven by the pressure to extend market protection for numerous existing drugs with soon-to-expire patents.

Publication Date: March 2007

     
About Greystone Reports

Our reports are carefully researched and written to provide timely and insightful analysis of key factors and developments shaping the commercial marketplace. The focused nature of our publications is designed to allow readers to identify emerging demand and growth opportunities in selected markets. Numerous charts, tables and graphs complement the text, with evaluations and assessments of current and probable future market developments, technology issues and business factors - information necessary to compete effectively in the global marketplace.